63 related articles for article (PubMed ID: 16868641)
1. Imaging of recurrent brain tumors with trivalent (99m)Tc-dimercaptosuccinic acid - initial results.
Barai S; Bandopadhayaya G; Julka P; Malhotra A; Naik K; Haloi A; Seith A; Halanaik D
Hell J Nucl Med; 2004; 7(1):44-7. PubMed ID: 16868641
[TBL] [Abstract][Full Text] [Related]
2. Glioma residual or recurrence versus radiation necrosis: accuracy of pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT compared to proton magnetic resonance spectroscopy (1H-MRS): initial results.
Amin A; Moustafa H; Ahmed E; El-Toukhy M
J Neurooncol; 2012 Feb; 106(3):579-87. PubMed ID: 21912937
[TBL] [Abstract][Full Text] [Related]
3. Pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT: does it have a place in predicting survival in patients with glioblastoma multiforme?
Amin A; Mustafa M; Abd El-Hadi E; Monier A; Badwey A; Saad E
J Neurooncol; 2015 Jan; 121(2):303-9. PubMed ID: 25349131
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m(V)-DMSA and thallium-201 in brain tumor imaging: correlation with histology and malignant grade.
Hirano T; Otake H; Kazama K; Wakabayashi K; Zama A; Shibasaki T; Tamura M; Endo K
J Nucl Med; 1997 Nov; 38(11):1741-9. PubMed ID: 9374344
[TBL] [Abstract][Full Text] [Related]
5. Delineation of target volume for radiotherapy of high-grade gliomas by 99m Tc-MIBI SPECT and MRI fusion.
Krengli M; Loi G; Sacchetti G; Manfredda I; Gambaro G; Brambilla M; Carriero A; Inglese E
Strahlenther Onkol; 2007 Dec; 183(12):689-94. PubMed ID: 18040614
[TBL] [Abstract][Full Text] [Related]
6. From outside to inside? Dose-dependent renal tubular damage after high-dose peptide receptor radionuclide therapy in rats measured with in vivo (99m)Tc-DMSA-SPECT and molecular imaging.
Forrer F; Rolleman E; Bijster M; Melis M; Bernard B; Krenning EP; de Jong M
Cancer Biother Radiopharm; 2007 Feb; 22(1):40-9. PubMed ID: 17627412
[TBL] [Abstract][Full Text] [Related]
7. Pentavalent Tc-99m dimercaptosuccinic acid imaging of hepatocellular carcinoma.
Wang SJ; Lin WY; Wey SP; Shen LH; Ting G
Neoplasma; 1999; 46(4):246-8. PubMed ID: 10613606
[TBL] [Abstract][Full Text] [Related]
8. Pentavalent technetium-99m dimercaptosuccinic acid [99m Tc-(V)DMSA] brain scintitomography--a plausible non-invasive depicter of glioblastoma proliferation and therapy response.
Tsiouris S; Pirmettis I; Chatzipanagiotou T; Ptohis N; Papantoniou V
J Neurooncol; 2007 Dec; 85(3):291-5. PubMed ID: 17554495
[TBL] [Abstract][Full Text] [Related]
9. Morphology and release kinetics of technetium-99m(V) dimercaptosuccinic acid loaded, poly(lactic-co-glycolic)acid microspheric delivery system. An experimental approach that may be used for targeted radiation treatment.
Shukla J; Bandopadhyaya GP; Varma IK; Kumar R; Maulik SK
Hell J Nucl Med; 2007; 10(1):9-13. PubMed ID: 17450243
[TBL] [Abstract][Full Text] [Related]
10. (99m)Tc(V)DMSA quantitatively predicts (188)Re(V)DMSA distribution in patients with prostate cancer metastatic to bone.
Blower PJ; Kettle AG; O'Doherty MJ; Coakley AJ; Knapp FF
Eur J Nucl Med; 2000 Sep; 27(9):1405-9. PubMed ID: 25084779
[TBL] [Abstract][Full Text] [Related]
11. Posttherapy technetium-99m pentavalent dimercaptosuccinic acid brain single-photon emission computed tomography/computed tomography: diagnostic and prognostic values in patients with glioma.
Mohamadien NRA; Diab WA; Abd El-Ghani WMA; Abdelhafez YG
Nucl Med Commun; 2022 Dec; 43(12):1195-1203. PubMed ID: 36345764
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Tc-99m (V) DMSA binding to human plasma proteins.
Lee BF; Yeh JL; Chiu NT; Liu GC; Yu HS; Wang MH; Shen LH
Kaohsiung J Med Sci; 2008 Jan; 24(1):1-9. PubMed ID: 18218563
[TBL] [Abstract][Full Text] [Related]
13. A Novel Metal-Based Imaging Probe for Targeted Dual-Modality SPECT/MR Imaging of Angiogenesis.
Tsoukalas C; Psimadas D; Kastis GA; Koutoulidis V; Harris AL; Paravatou-Petsotas M; Karageorgou M; Furenlid LR; Moulopoulos LA; Stamopoulos D; Bouziotis P
Front Chem; 2018; 6():224. PubMed ID: 29974048
[TBL] [Abstract][Full Text] [Related]
14. Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography.
Krishnamurthy A; Kumar RK; Ravishankaran P; Ramshankar V; Balkis Begum AS; Rangarajan GK
Indian J Nucl Med; 2014 Jul; 29(3):146-50. PubMed ID: 25210279
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Technetium-99m glucoheptonate single photon emission computed tomography for brain tumor grading.
Alam SS; Junaid S; Ahmed SM
Asian J Neurosurg; 2016; 11(2):118-28. PubMed ID: 27057217
[TBL] [Abstract][Full Text] [Related]
16. [
Vallejo-Armenta P; Ferro-Flores G; Santos-Cuevas C; García-Pérez FO; Casanova-Triviño P; Sandoval-Bonilla B; Ocampo-García B; Azorín-Vega E; Luna-Gutiérrez M
Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745648
[TBL] [Abstract][Full Text] [Related]
17. Data on biodistribution and dose calculation of
Bagheri M; DorriGiv M; Hejazi M; Fouladi MR; Parach AA
Data Brief; 2020 Oct; 32():106232. PubMed ID: 32939384
[TBL] [Abstract][Full Text] [Related]
18. Use of 99m-technetium-glucoheptonate as a tracer for brain tumor imaging: An overview of its strengths and pitfalls.
Santra A; Kumar R; Sharma P
Indian J Nucl Med; 2015; 30(1):1-8. PubMed ID: 25589798
[TBL] [Abstract][Full Text] [Related]
19. Utility of non-enhanced magnetic resonance imaging to detect acute pyelonephritis.
Aoyagi J; Odaka J; Kuroiwa Y; Nakashima N; Ito T; Saito T; Kanai T; Yamagata T; Momoi MY
Pediatr Int; 2014 Jun; 56(3):e4-6. PubMed ID: 24894941
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
